MetLife Q3 2024 Adj EPS $1.95 Misses $2.18 Estimate, Adj Sales $17.61B Miss $18.66B Estimate
Portfolio Pulse from Benzinga Newsdesk
MetLife's Q3 2024 adjusted earnings per share (EPS) and sales both missed analyst estimates. The EPS was $1.95, below the $2.18 estimate, and sales were $17.61 billion, below the $18.66 billion estimate. Both figures also showed a decline compared to the same period last year.
October 30, 2024 | 8:17 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
MetLife's Q3 2024 earnings and sales missed analyst expectations, with EPS at $1.95 versus the $2.18 estimate and sales at $17.61 billion versus the $18.66 billion estimate. Both metrics also declined year-over-year.
MetLife's Q3 2024 earnings and sales both missed analyst estimates, which is likely to negatively impact the stock price in the short term. The EPS miss was significant at 10.55%, and sales were 5.59% below expectations. Additionally, both EPS and sales showed a year-over-year decline, further contributing to a negative outlook.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100